Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Krar Kadhim Mohammed Jawad"'
Publikováno v:
International Journal of Applied Pharmaceutics. :71-79
Objective: The aim of this study was to formulate, evaluate and characterise nanoemulsion formulation containing a lipophilic drug, Ketoprofen. Methods: Nanoemulsion formulations composed of oil, surfactant, co-surfactants and Ketoprofen were prepare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1354c1102b01d3208cf7d883bb039334
https://doi.org/10.22159/ijap.2023v15i3.46892
https://doi.org/10.22159/ijap.2023v15i3.46892
Autor:
MAZIN THAMIR ABDUL-HASAN, KRAR KADHIM MOHAMMED JAWAD, ABULFADHEL JABER NEAMAH Al-SHAIBANI, KARRAR MOHAMMED HASAN AL-GBURI
Publikováno v:
International Journal of Applied Pharmaceutics. :48-52
Objective: The purpose of this study is to evaluate the quality control of marketed tablets containing propranolol hydrochloride available on the Iraqi market and manufactured by different companies. Methods: Different batches of propranolol hydrochl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecf9865990e429e4f2bc9a772986220b
https://doi.org/10.22159/ijap.2022v14i2.43756
https://doi.org/10.22159/ijap.2022v14i2.43756
Publikováno v:
ScienceRise: Pharmaceutical Science; No. 6(40) (2022); 21-28
ScienceRise: Pharmaceutical Science; № 6(40) (2022); 21-28
ScienceRise: Pharmaceutical Science; № 6(40) (2022); 21-28
The aim of the work is to consolidate azilsartan-kamedoxomil (AZM) into lipid matrix controlled-release microparticles to enhance its permeability because AZM belongs to Biopharmaceutical classification (BCS) IV which characterized by poor permeabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb918d00ce16dc3c36638b7c2078d5a
https://zenodo.org/record/7540689
https://zenodo.org/record/7540689
